Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Translational Oncology|May 6, 2022
A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutationsJing Ma, Xuelu Li, Qianran Zhang, et al.
Oncotargets and Therapy|March 31, 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancerXuelu Li, Chen Song, Gena Huang, et al.
Oncotarget|October 11, 2014
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsDan Wang, Ping Lu, Hao Zhang, et al.
Oncotarget|May 20, 2021
Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsDan Wang, Ping Lu, Hao Zhang, et al.
Frontiers in Oncology|February 12, 2024
mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutationYe Hu, Fengxi Chen, Siwen Sun, et al.
Cancer Cell International|August 11, 2020
Establishment and characterization of breast cancer organoids from a patient with mammary Paget's diseaseBo Pan, Dongyi Zhao, Yaqian Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 12, 2021
Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)Xuelu Li, Yitong Wang, Bo Pan, et al.
Oncotarget|April 1, 2015
Expression and clinicopathological significance of FSIP1 in breast cancerHao Zhang, Minna Luo, Zining Jin, et al.
Critical Reviews in Oncology/Hematology|December 25, 2023
Comprehensive review of solid tumor bone marrow metastasisLanxin Zhang, Fengxi Chen, Lingzhi Xu, et al.
International Journal of Public Health|January 1, 2025
The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019Ye Hu, Jiyue Gao, Qiping Zhuo, et al.
Pageof 7